LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q1 2026

Top Holdings563 positions

Checking export access…
Activity:
281.4M$1.5B8.4%——
13 qtrssince 2023-Q1
Decreased
0
93.6M$944.3M5.3%———
Increased
62
84.3M$595.4M3.3%———
Decreased
0
239.9M$488.6M2.7%———
Unchanged
0
130.5M$346.5M1.9%———
Increased
49
??MKS INC.
Bond
198.9M$329.8M1.8%———
Decreased
0
83.5M$281.2M1.6%———
Increased
49
275.6M$275.9M1.5%———
New
70
239M$268.5M1.5%———
Increased
54
249.4M$257.9M1.4%———
Unchanged
0
293.1M$244.7M1.4%———
Increased
66
253.8M$243.7M1.4%———
New
70
259.6M$242.7M1.4%———
Increased
49
193.8M$242.4M1.4%———
Increased
50
236.6M$227.5M1.3%———
Increased
55
92.7M$226.4M1.3%———
Decreased
0
132.7M$225.4M1.3%———
New
70
182.4M$210.2M1.2%———
Decreased
0
172.6M$205.8M1.2%———
Increased
54
??ASCENDIS PHARMA A/SDelisted
Bond
139.6M$205.5M1.2%———
Increased
49
$17.9B
AUM
563
Positions
Q1 2026
Filing
HI score · 2.5/5
Quarterly 13F Value Change
+1%Q4'24$12.1B+22%Q1'25$14.7B+10%Q2'25$16.3B-8%Q3'25$15B+8%Q4'25$16.2B+10%Q1'26$17.9B
Activity profile
$ moved · Q1'26
New32%Increased19%Decreased27%Exited23%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.9 quarters
<1Q28%1-4Q45%1-2Y17%2Y+10%

LINDEN ADVISORS LP manages $17.9B across 563 positions as of Q1 2026. Top holdings: LUMENTUM HLDGS INC (8.4%), LUMENTUM HLDGS INC (5.3%), LUMENTUM HLDGS INC (3.3%). Fund DNA: Momentum Trader. HoldingsIntel Score: 2.5/5.0.

Q1 2026 Summary

Active quarter - 160 new positions, 69 exits, 55 increased. No standout high-conviction moves this quarter. Portfolio: $17.9B across 563 positions.

Portfolio Allocation

Top holdings by portfolio weight

Total AUM$18B
LUMENTUM HLD8.43%
LUMENTUM HLD5.29%
LUMENTUM HLD3.33%
CENTRUS ENER2.74%
APPLIED DIGI1.94%
MKS INC.1.85%
SPHERE ENTER1.57%
UNITY SOFTWA1.54%
BRIDGEBIO PH1.50%
LIBERTY MEDI1.44%
Other1.37%
Sector Breakdown

Portfolio allocation by GICS sector

Sectors6
Financial Services77.25%
Unknown20.51%
Energy1.70%
Consumer Cyclical0.29%
Utilities0.20%
Communication Services0.05%
Fund DNA

Behavioral investing profile

Checking access…
Momentum Trader
Compare DNA across all funds
HoldingsIntel Score
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L57
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Dynasty Wealth Management, LLCDynasty Wealth Management, LLC
$13.5B
Magnetar Financial LLCMagnetar Financial LLC
$10.9B
Checking access…

Explore More

Compare LINDEN ADVISORS LP
Side-by-side holdings comparison
High-Conviction Picks
Top conviction positions this quarter
Double-Down Detection
Buying into price weakness
Best Trades
Top performing positions by P&L
All Momentum Trader Funds
Investing archetypes and behavior

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+151.4M shares+$192.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC.
Q4 2024 → Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 → Q2 2026+26.6M shares+$50.6M
Checking access…

Continue exploring

Explore high-conviction positions
See which stocks have the strongest institutional commitment
Compare with similar funds
Find portfolio overlap with LINDEN ADVISORS LP
Clone this fund
Backtest what copying LINDEN ADVISORS LP's portfolio would return

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used